7
Views
6
CrossRef citations to date
0
Altmetric
Biological Aspects and Prognostic Factors

Serum Vascular Endothelial Growth Factor Concentrations in Hepatocellular Cancer Patients Undergoing Percutaneously Radiofrequency Thermal Ablation

, , , , , , & show all
Pages 7-10 | Published online: 27 Oct 2016

References

  • Vermeulen PB, Gasparini G, Fox SB, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002; 38: 1564-79.
  • Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libu SK. Percutaneous tumor ablation with radiofrequency Cancer 2002, 94: 443-51.
  • Nicosia RF. What is the role of Vascular Endothelial Growth Factor-related molecules in tumor angiogenesis? Am J Pathol 1998; 153: 11-6.
  • Yamamoto Y, Masakazu T, Kondo S, et al. Concentration of Vascular Endothelial Growth Factor in the sera of normal controls and cancer patients. Clin Cancer Res 1996; 2: 821-6.
  • Chao Y, Li CP, Chau GY, et al. Prognostic significance of vascular endothelial growth factor, fibroblast growth factor, and angiogenin in patients with resecable hepatocellular carcinoma after surgery. Ann Surg Oncol 2003; 10: 355-62.
  • Li XM, Tang ZY, Qin LX, Zhou J, Sun HC. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 1999; 18: 511-7.
  • Zhao Y, Hu J, Cai J, Yang X, Yang Z. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Chin Med J 2003; 116: 772-6.
  • Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. Am J Roentgenol 2004; 183: 361-8.
  • Ranieri G, Coviello M, Chiriatti A, et al. Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls. Oncol Rep 2004; 11: 435-9.
  • Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of Vascular Endothelial Growth Factor. Clin Cancer Res 1999; 5: 487-91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.